Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

547.96
-22.6300-3.97%
Pre-market: 548.090.1300+0.02%08:30 EDT
Volume:998.62K
Turnover:552.23M
Market Cap:59.16B
PE:13.90
High:574.75
Open:574.15
Low:546.28
Close:570.59
Loading ...
Aug 18, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Aug 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Major Issues Report

8-K - Current report
Apr 10, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Major Issues Report

8-K - Current report
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 03, 2023

Major Issues Report

8-K - Current report
Jan 11, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals